Mounjaro muscle loss vs Ozempic: what the trials show and what to do about it
On Mounjaro muscle loss vs Ozempic, the trials do not show that one drug is clearly worse for muscle. In the body-scan sub-studies, lean mass was close to 40% of the weight lost on semaglutide (Ozempic and Wegovy) and about 25% on tirzepatide (Mounjaro and Zepbound). They were different trials, with different people and lengths, so the numbers cannot be lined up as a head-to-head result. The plan to protect muscle is the same for both: enough protein and lifting.
Not sure how much protein you need? The free 2-minute check gives your daily target in grams. Below: the two sets of numbers, why they mislead, what bigger weight loss means for muscle, and one plan that fits either drug.
The numbers: semaglutide and tirzepatide side by side
| Semaglutide (Ozempic, Wegovy) | Tirzepatide (Mounjaro, Zepbound) | |
|---|---|---|
| Trial with a body scan | STEP 1 sub-study, about 140 people | SURMOUNT-1 sub-study, about 160 people |
| Length | 68 weeks | 72 weeks |
| Scan type | DXA (measures lean mass, not just muscle) | DXA |
| Lean share of weight lost | Close to 40% | About 25%, like the placebo group |
| People studied | Adults with overweight or obesity, without diabetes | Adults with obesity or overweight, without diabetes |
These are the figures also used in our guide to what percentage of weight loss on GLP-1 is muscle. Early reports of a newer comparison between the two drugs have said tirzepatide lost more lean mass in total, but we could not find the paper reviewed and published, so we do not rely on it. Check for updates.
Why you cannot read the table as "Ozempic is worse"
- Different trials. Different participants, different follow-up, different scan machines and methods.
- DXA lean mass is not muscle. It counts water, organs and connective tissue too. A share of "lean" loss may be water or a smaller liver, not weakness.
- A share is not a total. A drug with greater weight loss can lose less lean tissue as a share and more in kilos.
- Small sub-studies. A hundred or so people can swing the percentage.
- Diet and training weren't controlled for muscle. The trials were not designed to protect muscle, so they show what happens when nobody tries.
Mounjaro muscle loss vs Ozempic: does the drug or the weight loss cause it?
Losing a lot of weight fast tends to lose some lean tissue with fat, on any drug, on a low-calorie diet, or after bariatric surgery. Some sources argue that lean loss tracks mainly with how much weight is lost, not with a direct effect of the drug on muscle. The more you lose, and the less protein you eat and the less you lift, the more lean mass tends to go. Tirzepatide on average produces more weight loss than semaglutide, which is a reason to take the muscle plan seriously if you are on it, not a reason to switch drugs. Which drug you take is a decision for you and your prescriber, based on your health, cost and side effects.
For the mechanisms, see what causes muscle loss on GLP-1.
One plan that fits both drugs
| Lever | What to do | Guide |
|---|---|---|
| Protein | About 1.2–1.6 g per kg of body weight a day, split across 4–5 small eatings | how much protein on GLP-1 |
| Lifting | Full-body, 2–3 days a week, near effort | GLP-1 workout plan |
| Pace | Ask your prescriber if your loss rate suits you; very fast loss costs more lean tissue | how to prevent muscle loss |
| Check | Chair stands and lifts monthly, not just the scale | symptoms of muscle loss |
What to expect by drug: appetite and food
Many people on tirzepatide report a bigger drop in appetite, and weight loss in trials averaged more than with semaglutide. Smaller appetite makes protein harder, because the target stays the same while the volume you can eat shrinks. If that is you, plan liquids and small, dense foods: what to eat on GLP-1 when you are not hungry and protein shakes on GLP-1. Your appetite is individual; the plan starts from what you actually eat.
Signs to watch, whichever drug you take
- Stairs, getting up from a chair or carrying groceries got harder.
- Your lifting weights drop for several weeks in a row.
- Your grip feels weaker or your clothes loosen while your shape looks "softer".
- You are very tired most days.
One or two of these can come from low calories, poor sleep or stress; several, over weeks, are worth raising with your clinician. A body scan can add information, but read it carefully: DEXA scan on GLP-1.
If you are thinking of switching drugs
Do not switch because of a muscle headline. Reasons to talk to your prescriber about a change are side effects, cost, supply and whether the drug is working for your health goals. If you do switch, keep your protein and lifting the same, as these are what you control. Also expect a change in appetite and nausea for a few weeks.
Who is most at risk, on either drug
Anyone losing weight quickly can lose lean tissue, but some people have less to spare. Adults over 60 or 65 start with less muscle and lose it faster with age, a process called sarcopenia, so a drop matters more to them. People who were not active before starting, who eat little protein, who have a very small appetite, or who lose more than they planned each week are also at higher risk. If you are in one of these groups, your prescriber may want to review the dose or pace, and a dietitian can help with protein. See GLP-1 strength training at home for a gentle start.
Does the dose change muscle loss?
Higher doses mean more weight loss on average, and more loss means more lean tissue in kilos. There is no trial showing that a particular dose step damages muscle more, so the practical rule is about the pace of loss: if you are losing much faster than you or your prescriber planned, or you cannot eat enough protein, tell them before the next increase. Do not skip or lower doses yourself without advice.
A four-week start if you are on either drug
| Week | Food | Training |
|---|---|---|
| 1 | Find your protein baseline: write down everything for three days | Two 20-minute sessions: sit-to-stands, rows, push-ups from a counter |
| 2 | Add one 20 g protein serving a day (yogurt, shake, eggs) | Add a third set to each move |
| 3 | Reach your target on 4 of 7 days | Three sessions; add a little weight |
| 4 | Reach it on 5 of 7 days; keep the log | Repeat the chair-stand test and compare with week 1 |
The chair-stand test is simple: count how many times you can stand up from a chair, arms crossed, in 30 seconds. The steps and the numbers to compare against are in our symptoms of muscle loss guide.
What to ask your prescriber or dietitian
- "What is a safe pace of weight loss for me?"
- "What daily protein target should I use, given my kidneys and any other conditions?"
- "Would a body scan help in my case, and who pays for it?"
- "If my appetite is very small, is there anything to adjust?"
- "Can I be referred to a dietitian or physical therapist?"
What happens to muscle after you stop either drug
In the follow-up of the semaglutide trial, most of the weight returned within a year after stopping, and regained weight tends to be fat first. If muscle was lost on the way down, it does not automatically return. Lifting and protein are the way to rebuild; the same plan applies after stopping, as we cover in muscle loss after GLP-1 and strength training after GLP-1.
Questions people ask
Does Mounjaro cause more muscle loss than Ozempic?
The published sub-studies do not show it. Lean mass was about a quarter of weight lost on tirzepatide and close to 40% on semaglutide, but in different trials. Tirzepatide's larger average weight loss can mean more lean tissue lost in kilos.
Is muscle loss on Wegovy the same as on Ozempic?
They are the same drug at different doses and uses, so the same trial numbers and the same plan apply.
How much muscle will I lose on Mounjaro?
There is no single number. It depends on how much weight you lose, your protein, your training and your age. Eating enough protein and lifting reduces the share that is lean tissue, though we cannot promise a result.
Can I prevent muscle loss on Mounjaro?
You can lower the risk with protein, lifting two to three times a week and sleep. See how to prevent muscle loss on GLP-1.
Which GLP-1 is best for keeping muscle?
No drug has been shown to be best at it. The biggest differences come from what you eat and how you train.
Should I get a DEXA scan on Mounjaro or Ozempic?
It can help if you want numbers, but it measures lean mass, not just muscle. Ask your prescriber whether it makes sense for you.
On tirzepatide? Our six steps are in Zepbound muscle loss prevention.
Same plan, whichever drug
The free 2-minute check gives your daily protein target in grams: the first number in any muscle plan.
Show my targetMore on eating and training on weight-loss medication: all our muscle plan guides.
Sources: Wilding JPH et al., Once-weekly semaglutide in adults with overweight or obesity (STEP 1), N Engl J Med 2021, and its body composition sub-study. Jastreboff AM et al., Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1), N Engl J Med 2022, and its DXA sub-study. Mozaffarian D et al., Nutritional priorities to support GLP-1 therapy for obesity, joint advisory, 2025. General information, not medical advice.